Karleigh McClain of Hendersonville, Tennessee, signed up for a membership with a telehealth company in January so that she could start taking a GLP-1 drug for weight loss
One well-known GLP-1 receptor agonist is Ozempic
GPCR endocytosis is in many cases dependent on the recruitment of -arrestins, which interact with clathrin adaptors to promote internalization via clathrin-coated pits 33
Because the medication addresses the underlying biology of hunger and metabolism rather than relying on willpower alone, it tends to produce more durable change than crash dieting, which typically triggers compensatory hunger and rebound weight gain
In a retrospective analysis of 177 patients on oral semaglutide, weight loss velocity decelerates sharply after 3 months from 1.99 kg/month in the first month to 0.18 kg/month between months 6 and 12 and a 23% weight rebound is already measurable by month 18 (Makkar et al., 2026)
Les effets secondaires frquents de la supplmentation en glutathion Bien que le glutathion soit une molcule endogne, son apport sous forme de complment alimentaire nest pas neutre